Renoparenchymal Hypertension - Embolisation Treatment

Professor P. Bosnjakovic
Institute of Radiology Clinical Centre, Nis, Serbia & Montenegro

Patient History

  • Male patient with hypertension, poorly controlled and on medication therapy.
  • Non-functional left kidney.

Procedure

  • Left kidney embolised using 2ml Bead Block.
Bead Block Case 7 fig 1

Left kidney pre-embolisation

Bead Block Case 7 fig 2

Left kidney post-embolisation

Outcome

  • Ultrasound (i) shows significantly reduced kidney size.
  • Angiogram (ii) shows reduced diameter of the left renal artery.
Bead Block Case 7 fig 3

i. One month post-embolisation

Bead Block Case 7 fig 4

ii. Two months post-embolisation

Clinical Outcome

  • Hypertension controlled well with one-third of medication compared with dose required pre-intervention.

Regulatory Notices

Worldwide (excluding USA)

Bead Block™ is CE marked and indicated for the treatment of a variety of hypervascular tumours (including Uterine Fibroids) and arteriovenous malformations (AVMs). Bead Block™ may not be indicated for the treatment of Uterine Fibroids in your country, please check with your local distributor. For full prescribing information please refer to Bead Block instructions for use.

USA

In the USA and Canada, Bead Block™ is indicated for the treatment of hypervascular tumors and arteriovenous malformations (AVMs). For full prescribing information please refer to Bead Block USA Instructions for use.